Doxazosin mesilate Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Hypertension and heart failure | Cardiovascular System
Items (12m)
872
Total Quantity
25.7K
NHS Cost
£750
vs National Avg
-18.4%
MAPLE ACCESS PARTNERSHIP LLP prescribed 872 items of Doxazosin mesilate over the last 12 months at a cost of £750 to the NHS. This is 18.4% below the national average prescribing rate. Doxazosin mesilate is classified under Hypertension and heart failure in the BNF.
Monthly Prescribing Trend
Jun 2026
76
Jun 2026
78
Jun 2026
73
Jun 2026
77
Jun 2026
69
Jun 2026
74
Jun 2026
92
Jun 2026
58
Jun 2026
70
Jun 2026
72
Jun 2026
69
Jun 2026
64
Prescribing Details
| Total Items | 872 |
|---|---|
| Total Quantity | 25,715 |
| Total NHS Cost | £750 |
| Presentations | 4 different forms |
| vs National Average | -18.4% |
Doxazosin mesilate Prescribing Comparison
| This practice | 872 items |
|---|---|
| National average per practice | 1,068 items |
| Difference | -18.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.